Product news from the 02/06/07 news brief

February 06 2007

GlaxoSmithKline said that the FDA has issued an approvable letter for its anti-clotting drug Arixtra (fondaparinux sodium).

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.